ResearcherVilnius UniversityNo recent work listed
Peter Schemmer
Matched on ORCID iD 0000-0002-4192-6155; OpenAlex author ID A5026259194. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2014: 3 papers · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper
Papers 7
- Establishment and Characterization of a New Pancreatic Ductal Adenocarcinoma Cell Line Capan-26. Co-author DOI 10.21873/anticanres.14897↗
- Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot study. Co-author DOI 10.1007/s10637-019-00826-z↗
- MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.01.038↗
- Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy. Co-author DOI 10.1038/cddis.2016.157↗
- Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Co-author DOI 10.1002/ijc.28583↗
- Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial. Last author DOI 10.1186/1745-6215-15-204↗
- Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Co-author DOI 10.18632/oncotarget.1764↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ingrid Herr · 6 shared papers, 2014–2020 · strength 0.34
- Paper Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-resul… DOI 10.1007/s10637-019-00826-z↗
- Paper Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemo… DOI 10.1038/cddis.2016.157↗
- Paper Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized … DOI 10.1186/1745-6215-15-204↗
- Thilo Hackert · 2 shared papers, 2014–2020 · strength 0.17
- Paper Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-resul… DOI 10.1007/s10637-019-00826-z↗
- Paper Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized … DOI 10.1186/1745-6215-15-204↗
- Vladimir J. Lozanovski · 2 shared papers, 2014–2020 · strength 0.17
- Paper Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-resul… DOI 10.1007/s10637-019-00826-z↗
- Paper Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized … DOI 10.1186/1745-6215-15-204↗
- Benediktas Kurlinkus · 1 shared paper, 2021 · strength 0.16
- Eglė Žalytė · 1 shared paper, 2021 · strength 0.16
- Mindaugas Valius · 1 shared paper, 2021 · strength 0.16
- Audrius Šileikis · 1 shared paper, 2021 · strength 0.16
- Nathalie Bauer · 3 shared papers, 2014–2016 · strength 0.14
- Paper Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemo… DOI 10.1038/cddis.2016.157↗
- Paper MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. DOI 10.1016/j.canlet.2016.01.038↗
- Paper Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF… DOI 10.1002/ijc.28583↗
- Clifford C. Nwaeburu · 3 shared papers, 2014–2016 · strength 0.12
- Paper MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. DOI 10.1016/j.canlet.2016.01.038↗
- Paper Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF… DOI 10.1002/ijc.28583↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Yefeng Yin · 2 shared papers, 2016 · strength 0.10
- Paper Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemo… DOI 10.1038/cddis.2016.157↗
- Paper MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. DOI 10.1016/j.canlet.2016.01.038↗
- Pei Fan · 2 shared papers, 2016 · strength 0.10
- Paper Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemo… DOI 10.1038/cddis.2016.157↗
- Paper MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. DOI 10.1016/j.canlet.2016.01.038↗
- Li Liu · 2 shared papers, 2014–2016 · strength 0.08
- Paper MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. DOI 10.1016/j.canlet.2016.01.038↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Yiyao Zhang · 2 shared papers, 2014–2016 · strength 0.08
- Paper MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer. DOI 10.1016/j.canlet.2016.01.038↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Jens Werner · 2 shared papers, 2014 · strength 0.07
- Paper Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF… DOI 10.1002/ijc.28583↗
- Paper Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional interc… DOI 10.18632/oncotarget.1764↗
- Alia Abukiwan · 1 shared paper, 2016 · strength 0.05
- Prince Saforo Amponsah · 1 shared paper, 2016 · strength 0.05
- Xi Xiao · 1 shared paper, 2016 · strength 0.05
- Li Liu · 1 shared paper, 2014 · strength 0.04
- Tobias Förster · 1 shared paper, 2014 · strength 0.03
- Michael Schaefer · 1 shared paper, 2014 · strength 0.03
- Nathalia A. Giese · 1 shared paper, 2014 · strength 0.03
- Orkhan Isayev · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.